Cipla with its subsidiary, Cipla USA has received approval for ANDA for Ambrisentan Tablets from the US drug regulator. The shares of the company were trading in red in the morning session.

Leading private banker Yes Bank's shares tumbled on Tuesday as the bank posted a loss of Rs. 1,507 crore for the March quarter. In the early morning session on Tuesday, the stock was down by more than 25 per cent at Rs. 177.90 per share.

Glenmark announced the launch of its patent-protected and globally-researched sodium glucose co-transporter-2 (SGLT2) inhibitor Remogliflozin etabonate in India. The drug is indicated in the treatment of type-2 diabetes mellitus in adults.

Overall volumes in futures & options currently stand at 1.10 crore contracts with a turnover of Rs. 7,32,837.82 crore.

Overall volumes in futures & options currently stand at 1.10 crore contracts with a turnover of Rs. 7,32,837.82 crore.

The previous week’s high of 11,797 is likely to act as a resistance level and a sustainable move above this level could set the stage for reclaiming the all-time high level of 11,856. On the downside, immediate support is seen around the level of 11,655, which is also the 20-day moving average. Stocks in news: JK Paper, Greaves Cotton, Sudarshan Chemical Industries, Sun Pharma, Dr Lal Pathlabs, Shankara Building Products, NBCC.

The Indian markets will resume trading after a long weekend and it will again go into another holiday on Wednesday this week. Hence, we might not see much action in the markets as traders might be reluctant to take any significant positions. However, we cannot rule out stock-specific action as over 40 companies are lined up to announce their earnings today. Looking at the early action among Asian peers and the SGX Nifty, the Nifty may open the day flat at 11,847 levels. Traders will also keep eye on India’s infrastructure output for the month of March which is due later in the day.

For Q4FY19, the bank reported profit after tax (PAT) of Rs. 72.3 crore as against a loss of Rs. 114 crore in Q4FY18. The bank's Net NPAs declined by around 2 per cent in the quarter.

In the fiscal year 2018-19, the Indian Stock market went through a roller coaster ride due to various reasons such as geopolitical tension, trade war, liquidity crisis caused by IL&FS default, rising crude oil prices and weakening of INR.

The company's GNPA and NNPA in Q4FY19 reduced to 2.3 per cent and 1.1 per cent from 3 per cent and 1.7 per cent in Q4FY18, respectively. The provision coverage ratio for the quarter was at 49.8 per cent as against 44.2 per cent in Q4FY18.